<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">2882</id>
  <title>T3D2840</title>
  <common-name>Fluphenazine</common-name>
  <description>Fluphenazine is only found in individuals that have used or taken this drug. It is a phenothiazine used in the treatment of psychoses. Its properties and uses are generally similar to those of chlorpromazine. [PubChem]Fluphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.</description>
  <cas>69-23-8</cas>
  <pubchem-id>3372</pubchem-id>
  <chemical-formula>C22H26F3N3OS</chemical-formula>
  <weight>437.174870</weight>
  <appearance>White powder.</appearance>
  <melting-point>224-226°C (Salt)</melting-point>
  <boiling-point>268-274°C at 5.00E-01 mm Hg</boiling-point>
  <density nil="true"/>
  <solubility>31.1 mg/L (at 37°C)</solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure>Oral, Intramuscular</route-of-exposure>
  <target nil="true"/>
  <mechanism-of-toxicity>Fluphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.</mechanism-of-toxicity>
  <metabolism></metabolism>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>For management of manifestations of psychotic disorders.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms></symptoms>
  <treatment nil="true"/>
  <created-at type="dateTime">2009-07-21T20:27:16Z</created-at>
  <updated-at type="dateTime">2014-12-24T20:25:52Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Fluphenazine</wikipedia>
  <uniprot-id></uniprot-id>
  <kegg-compound-id>C07010</kegg-compound-id>
  <omim-id></omim-id>
  <chebi-id>5123</chebi-id>
  <biocyc-id></biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id>Fluphenazine</stitch-id>
  <drugbank-id>DB00623</drugbank-id>
  <pdb-id></pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OCCN1CCN(CCCN2C3=CC=CC=C3SC3=C2C=C(C=C3)C(F)(F)F)CC1</moldb-smiles>
  <moldb-formula>C22H26F3N3OS</moldb-formula>
  <moldb-inchi>InChI=1S/C22H26F3N3OS/c23-22(24,25)17-6-7-21-19(16-17)28(18-4-1-2-5-20(18)30-21)9-3-8-26-10-12-27(13-11-26)14-15-29/h1-2,4-7,16,29H,3,8-15H2</moldb-inchi>
  <moldb-inchikey>InChIKey=PLDUPXSUYLZYBN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">437.522</moldb-average-mass>
  <moldb-mono-mass type="decimal">437.174867774</moldb-mono-mass>
  <origin>Exogenous</origin>
  <state>Solid</state>
  <logp>4.36</logp>
  <hmdb-id>HMDB14761</hmdb-id>
  <chembl-id>CHEMBL726</chembl-id>
  <chemspider-id>3255</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference>&lt;p&gt;Ullyot, G.E.; U.S. Patent 3,058,979; October 16, 1962; assigned to Smith Kline &amp;amp; French&lt;br /&gt;
Laboratories.&lt;/p&gt;</synthesis-reference>
  <structure-image-caption nil="true"/>
</compound>
